Sclerosis Clinical Trials in Sheffield, South Yorkshire
2 recruitingSheffield, South Yorkshire, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals360 enrolled99 locationsNCT06846281
Recruiting
Not Applicable
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
Pathologic ProcessesMultiple SclerosisAutoimmune Diseases+3 more
Sheffield Teaching Hospitals NHS Foundation Trust24 enrolled1 locationNCT04786821